mr 2034 has been researched along with levodopa in 1 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | mr 2034 (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schomburg, ED; Steffens, H; Wada, N | 1 |
1 other study(ies) available for mr 2034 and levodopa
| Article | Year |
|---|---|
Parallel nociceptive reflex pathways with negative and positive feedback functions to foot extensors in the cat.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzomorphans; Cats; Dopamine Agents; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalins; Feedback, Physiological; Foot; Levodopa; Locomotion; Mechanoreceptors; Monoamine Oxidase Inhibitors; Muscle, Skeletal; Neural Inhibition; Nialamide; Nociceptors; Physical Stimulation; Reflex; Spinal Cord; Tibial Nerve | 2001 |